Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Aug;12(8):e963.
doi: 10.1002/ctm2.963.

Ferroptosis vulnerability in MYCN-driven neuroblastomas

Affiliations
Comment

Ferroptosis vulnerability in MYCN-driven neuroblastomas

Shayani Dasgupta et al. Clin Transl Med. 2022 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Boyi Gan is an inventor of patent applications involving targeting ferroptosis in cancer therapy. Shayani Dasgupta has no conflicts of interest to declare.

Figures

FIGURE 1
FIGURE 1
Schematic shows combined inhibition of cystine uptake (by IKE), cysteine de novo synthesis (by propargylglycine [PPG] to block CTH, a key enzyme involved in cysteine synthesis) and GPX4 (by GPX4 CRISPR knockout) depletes intracellular cysteine and GSH availability, and effectively triggers ferroptosis in MYCN‐high neuroblastomas.

Comment on

  • MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis.
    Alborzinia H, Flórez AF, Kreth S, Brückner LM, Yildiz U, Gartlgruber M, Odoni DI, Poschet G, Garbowicz K, Shao C, Klein C, Meier J, Zeisberger P, Nadler-Holly M, Ziehm M, Paul F, Burhenne J, Bell E, Shaikhkarami M, Würth R, Stainczyk SA, Wecht EM, Kreth J, Büttner M, Ishaque N, Schlesner M, Nicke B, Stresemann C, Llamazares-Prada M, Reiling JH, Fischer M, Amit I, Selbach M, Herrmann C, Wölfl S, Henrich KO, Höfer T, Trumpp A, Westermann F. Alborzinia H, et al. Nat Cancer. 2022 Apr;3(4):471-485. doi: 10.1038/s43018-022-00355-4. Epub 2022 Apr 28. Nat Cancer. 2022. PMID: 35484422 Free PMC article.

References

    1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646‐674. - PubMed
    1. Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22(7):381‐396. - PMC - PubMed
    1. Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron‐dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060‐1072. - PMC - PubMed
    1. Koppula P, Zhang Y, Zhuang L, et al. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun (Lond). 2018;38(1):12. - PMC - PubMed
    1. Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599‐620. - PMC - PubMed

Publication types

Substances